Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (US20180263997) PHARMACEUTICAL COMPOSITIONS COMPRISING A JAK INHIBITOR

Office : United States of America
Application Number: 15918765 Application Date: 12.03.2018
Publication Number: 20180263997 Publication Date: 20.09.2018
Publication Kind : A1
IPC:
A61K 31/541
A61K 9/20
A61K 47/12
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
54
having six-membered rings with at least one nitrogen and at least one sulfur as the ring hetero atoms, e.g. sulthiame
541
Non-condensed thiazines containing further heterocyclic rings
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9
Medicinal preparations characterised by special physical form
20
Pills, lozenges or tablets
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
06
Organic compounds
08
containing oxygen
12
Carboxylic acids; Salts or anhydrides thereof
CPC:
A61K 31/541
A61K 47/12
A61K 9/20
A61K 9/2009
A61K 9/2013
A61K 9/2018
A61K 9/2054
A61K 9/2059
Applicants: Gilead Sciences, Inc
Inventors: David Alonzo
Bei Li
Dimitrios Stefanidis
Priority Data:
Title: (EN) PHARMACEUTICAL COMPOSITIONS COMPRISING A JAK INHIBITOR
Abstract: front page image
(EN)

Pharmaceutical compositions comprising filgotinib maleate Form I and uses thereof are described herein.